Search for: "BOEHRINGER INGELHEIM CORP."
Results 1 - 20
of 53
Sort by Relevance
|
Sort by Date
5 Apr 2020, 9:57 pm
Plaintiffs-Appellants Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH; Boehringer Ingelheim Corp.; and Boehringer Ingelheim... [read post]
1 Aug 2019, 8:30 am
Boehringer Ingelheim Corp., et al., a $150 million settlement with GlaxoSmithKline PLC, and a $190 million settlement with Aventis Pharmaceuticals, Inc. [read post]
21 Jul 2019, 7:55 pm
Several years ago, I covered in the Western Journal of Legal Studies the emergence of class actions as a viable mechanism to promote privacy interests in the public. [read post]
4 Sep 2018, 7:00 am
Boehringer Ingelheim Pharmaceuticals, Inc., 892 F.3d 1264 (D.C. [read post]
4 Sep 2018, 7:00 am
Boehringer Ingelheim Pharmaceuticals, Inc., 892 F.3d 1264 (D.C. [read post]
4 Mar 2015, 1:32 pm
Last week, MBBP’s Scott Bleier attended a panel discussion hosted by the Johnson & Johnson Boston Innovation Center, which featured three corporate venture capitalists from Sanofi-Genzyme Bioventures, Boehringer Ingelheim Venture USA Inc. and Johnson & Johnson Development Corp. [read post]
28 Jul 2014, 8:38 am
Boehringer Ingelheim Vetmedica, Inc. v. [read post]
25 Jul 2014, 8:04 am
Boehringer Ingelheim Vetmedica, Inc. v. [read post]
24 Dec 2013, 5:49 am
” Boehringer Ingelheim Vetmedica, Inc. v. [read post]
19 Aug 2013, 8:39 am
Boehringer Ingelheim Corp. [read post]
17 Jun 2013, 10:27 am
” Boehringer Ingelheim Vetmedica v. [read post]
23 Jan 2013, 4:16 pm
” Boehringer Ingelheim Vetmedica, Inc. v. [read post]
25 Nov 2012, 1:10 pm
Medik had argued, citing Celanese international Corp v BP Chemicals Ltd [1999] RPC 203, that it was entitled to deduct a portion of general overheads - cost of premises and general staff costs. [read post]
2 Nov 2012, 11:58 am
Boehringer Ingelheim Pharmaceuticals, Inc., 2009 WL 702007, at *3-4 (D. [read post]
22 Oct 2012, 8:28 am
Boehringer Ingelheim Corp. [read post]
20 Aug 2012, 11:15 am
Since coming on the market in October 2010 the FDA has received numerous Adverse Event Reports involving: • Serious bleeding side effects • Hemorrhages such as hemorrhagic stroke In addition, some medical studies have associated Pradaxa with an increased risk: • Heart attack • Myocardial infarction (MI)• Acute coronary syndrome (ACS) Due to these serious side effects, a growing number of personal injury and wrongful death Pradaxa lawsuits have been filed against… [read post]
13 Mar 2012, 10:10 am
Oral argument argued before the Eighth Circuit U.S. [read post]
29 Dec 2011, 6:53 am
Happy Christmas/Hanukkah/solstice and Merry New Year to all our readers. [read post]
31 Jan 2011, 8:10 am
Terminal Disclaimers and Section 121 Boehringer Ingelheim International GmbH v. [read post]
31 Jan 2011, 8:10 am
Terminal Disclaimers and Section 121 Boehringer Ingelheim International GmbH v. [read post]
